Showing Articles for
Cancer
J&J Cleared in PA Talc Trial
MedTruth Editors · October 5, 2021
A jury acquitted Johnson & Johnson of civil liability for one woman’s ovarian cancer.
Legal DevelopmentsJudge Prevents Injunction Against J&J Asset Splitting
MedTruth Editors · September 30, 2021
The plaintiffs argue that this financial maneuver would unlawfully shield Johnson & Johnson from any liability the company may owe for its talcum powder’s connection to ovarian cancer.
Legal DevelopmentsDates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsGet our reporting in your inbox
J&J Returns to Court In “Ground Zero” For Ovarian Cancer Lawsuits
MedTruth Editors · September 24, 2021
The first J&J talcum powder trial since before the pandemic has begun in Missouri over ovarian cancer claims.
Legal DevelopmentsNewly-Released Internal EPA Report Links Glyphosate to Cancer
MedTruth Editors · September 8, 2021
An internal EPA document from 2016 suggested that several studies reported elevated risks of non-Hodgkin's lymphoma associated with glyphosate exposure.
NewsJ&J Hit With $26.5 Million Talc Verdict
MedTruth Editors · September 2, 2021
Christina Prudencio's lawyer claimed her terminal mesothelioma was rooted in Johnson & Johnson ignoring decades of proof that their talcum products were unsafe.
Legal DevelopmentsJ&J Concealed Talc Risks To Preserve Brand Image, Philly Jury Told
MedTruth Editors · September 1, 2021
The plaintiff in a Philadelphia trial claimed J&J was aware that its baby powder was associated with cancer risk but withheld that information for decades in order to protect its brand image.
NewsSupreme Court Allows Johnson & Johnson's $2 Billion Baby Powder Cancer Verdict
MedTruth Editors · June 7, 2021
The Supreme Court has allowed a $2.1 billion baby powder cancer verdict against Johnson & Johnson to stand.
NewsJohnson and Johnson Talcum Powder Lawsuits: Recent Developments
Guest Contributor · January 29, 2021
An update on lawsuits claiming J&J's talcum powder causes ovarian cancer.
Legal DevelopmentsFibroid Removal Safety Recommendations Updated by FDA
Carah Wertheimer · January 7, 2021
The FDA has finalized safety recommendations for the use of power morcellators in surgeries to remove fibroids.
FDA Regulation$2.1 Billion Talcum Powder Cancer Verdict Stands, J&J Appealing to Supreme Court
James Parker · November 12, 2020
Johnson & Johnson intends to appeal a record $2.1 billion talc verdict after striking out in the Missouri Supreme Court.
Legal DevelopmentsNew Blood Test Detects Cancer Up to 4 Years Before Diagnosis
Carah Wertheimer · September 18, 2020
A cutting-edge blood test can detect five common cancers up to four years before most people even know they have the disease.
NewsNo Increased Risk of Most Cancers From Hair Dye, Study Says
Carah Wertheimer · September 14, 2020
A major study found no increased risk of most types of cancer in women who use permanent hair dye at home.
Research + FindingsCalifornia Attorneys Seek to Consolidate Zantac Lawsuits
James Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsHow to Navigate Statutes of Limitation in Talc-Cancer Claims
Lynne Higby · May 27, 2020
Questions about the statute of limitations for ovarian cancer wrongful death claims have been raised by the families of women who used Johnson & Johnson's talcum powder products.
Legal DevelopmentsJohnson & Johnson Discontinues Talcum Powder in the U.S. & Canada
Carah Wertheimer · May 19, 2020
J&J will withdraw its signature talcum powder from North American markets, insisting the product is safe despite nearly 20,000 lawsuits alleging that asbestos-contaminated powder caused cancer.
NewsCoronavirus Delays Chemotherapy for Cancer Patients
Benjamin Duong · April 16, 2020
Patients with cancer, already vulnerable with many dependent on regular treatment appointments, are facing delayed chemotherapy, surgeries and even outright cancellations.
NewsZantac and Ranitidine Products Removed from U.S. Market
Ashley Lombardo · April 1, 2020
On April 1, the U.S. Food and Drug Administration requested immediate removal of Zantac products from the U.S. market, including all prescription and over-the-counter medications containing ranitidine.
NewsJohnson & Johnson Talc Appeal Unhindered by COVID-19 Shutdown
James Parker · March 30, 2020
A Missouri appellate court set an April 24 date for Johnson & Johnson’s $4.69 billion talc appeal, despite the Missouri Supreme Court’s cancellation of all April arguments to reduce COVID-19 exposure.
Legal DevelopmentsChemical Hair Dyes and Straighteners May Increase Breast Cancer Risk
Benjamin Duong · March 2, 2020
Use of hair dyes and chemical hair straighteners may be associated with an increased risk of breast cancer, with black women being at an increased risk compared to white women.
Research + FindingsMT Weekly: J&J Asbestos Settlement, EPA to Regulate PFAS
Carah Wertheimer · February 25, 2020
This week, MedTruth provides updates on the latest baby powder settlement, the EPA's new regulations on PFAS, plus a study on the impacts of chemical exposure during pregnancy.
NewsiPap: The Emerging Future of Cervical Cancer Screening Technology
Tess Francke · January 21, 2020
A new, at-home cervical cancer screening test may just revolutionize early detection, especially in international markets that lack the infrastructure to provide easy access to doctors and regular pap smear tests.
Women's HealthExposure to Heat During Storage Causes Zantac Contamination
Benjamin Duong · January 14, 2020
Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.
NewsMore Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall
James Parker · January 13, 2020
Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.
FDA RegulationStudy Exploring Talc-Cancer Link Underrepresents Populations of Color
Benjamin Duong · January 13, 2020
A recent baby powder study found an insignificant link between the substance and ovarian cancer, but the study has limitations, including underrepresenting populations of color.
Research + FindingsFDA Schedules Public Meeting to Assess Testing for Asbestos in Talc
James Parker · January 13, 2020
The public meeting may be crucial to qualifying expert witnesses for thousands of plaintiffs involved in national talcum powder cases.
FDA RegulationFDA Metformin Probe Investigates Potential NDMA Hazard
James Parker · January 8, 2020
An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.
FDA RegulationLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsBreast Cancer Awareness Month 2019 Explores All Reconstruction Options
S. Nicole Lane · October 16, 2019
This October, in honor of Breast Cancer Awareness Month, MedTruth recognizes the AiRS Foundation, which supports cancer survivors by providing information and financial aid to those considering reconstruction. It's important to note that reconstruction isn't the only option. Some women are taking social media by storm, advising women to "choose flat."
Health FeaturesNew Patient Reporting Technology Empowers Cancer Patients, Offering Remote Care
Tess Francke · October 8, 2019
Recent studies have found that rural cancer patients face challenges in accessing quality care over their metropolitan counterparts, which may impact life expectancy. Noona, a new system designed to provide cancer patients care and symptom assessment from the comfort of their own home, may just change that.
MedTechWorried About Breast Cancer? Science Says Eat More Chicken, Less Red Meat
Carah Wertheimer · October 8, 2019
Research shows that women who consumed poultry rather than red meat had a significantly lower risk of breast cancer.
Research + FindingsAdaptive Radiotherapy: Cancer Treatment May Be Safer, More Accessible
Benjamin Duong · August 21, 2019
Adaptive radiotherapy is a form of personalized radiation therapy for cancer treatment. Although still in its early stages, clinicians hope that with further development to imaging methods, this form of cancer treatment will be a safer option to target tumors while minimizing tissue damage.
Research + FindingsIn the Lab: Ovarian Cancer Cells Show Mutation from Talc Exposure
Tess Francke · June 24, 2019
The link between talc powder and ovarian cancer has been warned about for years. Now, a recent study identifying evidence of cell mutation shows the way talc powder promotes the generation of ovarian cancer cells. This is the first study to confirm the cellular effect of talc.
Research + FindingsResearchers Develop New Blood Test to Detect Cancer in 10 Minutes
Tess Francke · April 11, 2019
It's a quest to detect multiple types of cancer in its early stages with the simple blood test that would take under 10 minutes to report results. Researchers say it will be at least five years before there is sufficient data to show whether it can work.
NewsWhy We Still Aren’t Educated Enough on Ovarian Cancer
S. Nicole Lane · November 14, 2018
A recent report found that many women don’t know that much about ovarian cancer whatsoever.
Women's HealthPreliminary Study Finds Ovarian Cancer May Start in Fallopian Tubes
Ashley Lombardo · October 25, 2017
An ovarian cancer study indicates the disease may originate in the fallopian tubes. Scientists used genome sequencing to examine DNA errors.
Research + Findings